
What smart money is saying about BioHarvest Sciences Inc.
1 fund in our archive has pitched BioHarvest Sciences Inc. — most recently Riverwater Small Cap Strategy in December 2025.
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Get an email when a fund writes about it
Position history
Between Q4 2025 and Q2 2026, 1 fund letter reported a position in BioHarvest Sciences Inc. — 1 trimmed or exited.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 1 | 0 |
| Q4 2025 | 0 | 0 | 0 | 1 |
Fund activity · 1 position · 1 move
- June 2026
“We exited BioHarvest Sciences (BHST), a small residual position, as we consolidated the portfolio's consumer staples exposure around Lifeway.”
Read the letterBioHarvest Sciences Inc.
Fund coverage · 1 thesis
- Riverwater Small Cap StrategyDecember 2025
BioHarvest Sciences develops a Botanical Synthesis platform and nutraceutical revenues with long-term compounding potential from scalable, sustainable production.
Read the full thesis
Read every full thesis on BioHarvest Sciences Inc.
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→